Annual Revenue
$12.73 M
-$537.00 K-4.05%
March 31, 2024
Summary
- As of March 13, 2025, SNOA annual revenue is $12.73 million, with the most recent change of -$537.00 thousand (-4.05%) on March 31, 2024.
- During the last 3 years, SNOA annual revenue has fallen by -$5.89 million (-31.64%).
- SNOA annual revenue is now -32.87% below its all-time high of $18.97 million, reached on March 31, 2019.
Performance
SNOA Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$3.56 M
-$15.00 K-0.42%
December 31, 2024
Summary
- As of March 13, 2025, SNOA quarterly revenue is $3.56 million, with the most recent change of -$15.00 thousand (-0.42%) on December 31, 2024.
- Over the past year, SNOA quarterly revenue has stayed the same.
- SNOA quarterly revenue is now -38.22% below its all-time high of $5.77 million, reached on September 30, 2020.
Performance
SNOA Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$13.97 M
+$426.00 K+3.14%
December 31, 2024
Summary
- As of March 13, 2025, SNOA TTM revenue is $13.97 million, with the most recent change of +$426.00 thousand (+3.14%) on December 31, 2024.
- Over the past year, SNOA TTM revenue has stayed the same.
- SNOA TTM revenue is now -32.77% below its all-time high of $20.78 million, reached on December 31, 2020.
Performance
SNOA TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
SNOA Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -4.0% | 0.0% | 0.0% |
| 3 y3 years | -31.6% | 0.0% | 0.0% |
| 5 y5 years | -32.9% | 0.0% | 0.0% |
SNOA Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -31.6% | +0.8% | -10.5% | +55.1% | at high | +15.3% |
| 5 y | 5-year | -32.9% | +0.8% | -38.2% | +65.2% | -32.8% | +15.3% |
| alltime | all time | -32.9% | +1311.9% | -38.2% | +951.3% | -32.8% | +4021.8% |
Sonoma Pharmaceuticals Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | $3.56 M(-0.4%) | $13.97 M(+3.1%) |
| Sep 2024 | - | $3.58 M(+5.5%) | $13.55 M(+6.7%) |
| Jun 2024 | - | $3.39 M(-1.4%) | $12.70 M(-0.3%) |
| Mar 2024 | $12.73 M(-4.0%) | $3.44 M(+9.6%) | $12.73 M(+3.5%) |
| Dec 2023 | - | $3.14 M(+14.9%) | $12.31 M(+1.6%) |
| Sep 2023 | - | $2.73 M(-20.3%) | $12.12 M(-4.7%) |
| Jun 2023 | - | $3.43 M(+13.7%) | $12.72 M(-4.2%) |
| Mar 2023 | $13.27 M(+5.1%) | $3.01 M(+2.4%) | $13.27 M(+5.7%) |
| Dec 2022 | - | $2.94 M(-11.6%) | $12.56 M(+0.3%) |
| Sep 2022 | - | $3.33 M(-16.4%) | $12.51 M(-3.2%) |
| Jun 2022 | - | $3.98 M(+73.3%) | $12.93 M(+2.4%) |
| Mar 2022 | $12.63 M(-32.2%) | $2.30 M(-20.8%) | $12.63 M(+1.1%) |
| Dec 2021 | - | $2.90 M(-22.5%) | $12.49 M(-14.0%) |
| Sep 2021 | - | $3.74 M(+1.6%) | $14.52 M(-12.2%) |
| Jun 2021 | - | $3.68 M(+70.8%) | $16.55 M(-11.2%) |
| Mar 2021 | $18.63 M(+3.9%) | $2.16 M(-56.3%) | $18.63 M(-10.4%) |
| Dec 2020 | - | $4.94 M(-14.4%) | $20.78 M(+2.7%) |
| Sep 2020 | - | $5.77 M(+0.0%) | $20.24 M(+5.4%) |
| Jun 2020 | - | $5.77 M(+33.7%) | $19.20 M(+7.1%) |
| Mar 2020 | $17.93 M(-5.5%) | $4.31 M(-1.9%) | $17.93 M(-0.4%) |
| Dec 2019 | - | $4.39 M(-7.0%) | $18.00 M(-4.7%) |
| Sep 2019 | - | $4.73 M(+5.2%) | $18.88 M(-1.1%) |
| Jun 2019 | - | $4.50 M(+2.6%) | $19.10 M(+0.7%) |
| Mar 2019 | $18.97 M(+13.9%) | $4.38 M(-17.0%) | $18.97 M(+4.0%) |
| Dec 2018 | - | $5.28 M(+6.9%) | $18.24 M(+2.5%) |
| Sep 2018 | - | $4.94 M(+13.0%) | $17.81 M(+3.6%) |
| Jun 2018 | - | $4.37 M(+19.5%) | $17.19 M(+3.2%) |
| Mar 2018 | $16.66 M(+29.9%) | $3.65 M(-24.5%) | $16.66 M(-2.2%) |
| Dec 2017 | - | $4.84 M(+12.0%) | $17.03 M(+9.5%) |
| Sep 2017 | - | $4.33 M(+12.8%) | $15.55 M(+10.9%) |
| Jun 2017 | - | $3.83 M(-4.8%) | $14.02 M(+9.3%) |
| Mar 2017 | $12.82 M(+36.9%) | $4.03 M(+19.9%) | $12.83 M(+12.8%) |
| Dec 2016 | - | $3.36 M(+20.1%) | $11.37 M(+8.4%) |
| Sep 2016 | - | $2.80 M(+6.1%) | $10.49 M(-10.7%) |
| Jun 2016 | - | $2.64 M(+2.4%) | $11.75 M(-8.1%) |
| Mar 2016 | $9.37 M(-32.4%) | $2.58 M(+3.7%) | $12.79 M(-9.9%) |
| Dec 2015 | - | $2.48 M(-38.8%) | $14.20 M(-4.9%) |
| Sep 2015 | - | $4.05 M(+10.2%) | $14.93 M(+5.6%) |
| Jun 2015 | - | $3.68 M(-7.5%) | $14.14 M(+2.1%) |
| Mar 2015 | $13.85 M(+1.4%) | $3.98 M(+23.7%) | $13.85 M(+8.3%) |
| Dec 2014 | - | $3.22 M(-1.4%) | $12.79 M(-0.6%) |
| Sep 2014 | - | $3.26 M(-3.8%) | $12.86 M(-6.0%) |
| Jun 2014 | - | $3.39 M(+16.4%) | $13.69 M(+0.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | $13.67 M(-11.5%) | $2.91 M(-11.5%) | $13.67 M(-3.0%) |
| Dec 2013 | - | $3.29 M(-19.5%) | $14.09 M(-1.7%) |
| Sep 2013 | - | $4.09 M(+21.3%) | $14.34 M(-3.0%) |
| Jun 2013 | - | $3.37 M(+1.1%) | $14.77 M(-4.4%) |
| Mar 2013 | $15.45 M(+21.2%) | $3.33 M(-5.8%) | $15.45 M(-0.1%) |
| Dec 2012 | - | $3.54 M(-21.8%) | $15.47 M(+5.1%) |
| Sep 2012 | - | $4.53 M(+11.7%) | $14.72 M(+6.2%) |
| Jun 2012 | - | $4.05 M(+20.9%) | $13.86 M(+8.7%) |
| Mar 2012 | $12.74 M(+30.7%) | $3.35 M(+20.1%) | $12.74 M(+5.3%) |
| Dec 2011 | - | $2.79 M(-23.8%) | $12.10 M(+4.1%) |
| Sep 2011 | - | $3.66 M(+24.6%) | $11.63 M(+11.5%) |
| Jun 2011 | - | $2.94 M(+8.4%) | $10.43 M(+6.9%) |
| Mar 2011 | $9.75 M(+32.5%) | $2.71 M(+17.2%) | $9.75 M(+5.2%) |
| Dec 2010 | - | $2.31 M(-6.2%) | $9.28 M(+8.2%) |
| Sep 2010 | - | $2.47 M(+8.9%) | $8.57 M(+10.2%) |
| Jun 2010 | - | $2.26 M(+1.4%) | $7.78 M(+5.7%) |
| Mar 2010 | $7.36 M(+36.7%) | $2.23 M(+38.4%) | $7.36 M(+11.5%) |
| Dec 2009 | - | $1.61 M(-3.5%) | $6.61 M(+6.3%) |
| Sep 2009 | - | $1.67 M(-9.5%) | $6.21 M(+3.2%) |
| Jun 2009 | - | $1.85 M(+25.2%) | $6.02 M(+11.8%) |
| Mar 2009 | $5.39 M(+40.5%) | $1.48 M(+20.8%) | $5.39 M(+11.3%) |
| Dec 2008 | - | $1.22 M(-17.6%) | $4.84 M(+3.3%) |
| Sep 2008 | - | $1.48 M(+22.3%) | $4.68 M(+12.1%) |
| Jun 2008 | - | $1.21 M(+30.8%) | $4.18 M(+9.0%) |
| Mar 2008 | $3.83 M(-15.6%) | $926.00 K(-13.1%) | $3.83 M(-5.8%) |
| Dec 2007 | - | $1.07 M(+9.1%) | $4.07 M(+0.3%) |
| Sep 2007 | - | $977.00 K(+12.8%) | $4.06 M(-6.3%) |
| Jun 2007 | - | $866.00 K(-25.5%) | $4.33 M(-6.5%) |
| Mar 2007 | $4.54 M(+75.8%) | $1.16 M(+10.5%) | $4.63 M(+9.7%) |
| Dec 2006 | - | $1.05 M(-16.0%) | $4.22 M(+7.7%) |
| Sep 2006 | - | $1.25 M(+7.5%) | $3.92 M(+22.2%) |
| Jun 2006 | - | $1.17 M(+55.1%) | $3.21 M(+24.1%) |
| Mar 2006 | $2.58 M(+90.6%) | $751.00 K(0.0%) | $2.58 M(+19.0%) |
| Dec 2005 | - | $751.00 K(+38.8%) | $2.17 M(+23.4%) |
| Sep 2005 | - | $541.00 K(0.0%) | $1.76 M(+13.0%) |
| Jun 2005 | - | $541.00 K(+59.6%) | $1.56 M(+14.9%) |
| Mar 2005 | $1.36 M(+50.3%) | $339.00 K(0.0%) | $1.36 M(+33.3%) |
| Dec 2004 | - | $339.00 K(0.0%) | $1.02 M(+50.0%) |
| Sep 2004 | - | $339.00 K(0.0%) | $678.00 K(+100.0%) |
| Jun 2004 | - | $339.00 K | $339.00 K |
| Mar 2004 | $902.00 K(-63.5%) | - | - |
| Mar 2003 | $2.47 M(+23.5%) | - | - |
| Mar 2002 | $2.00 M | - | - |
FAQ
- What is Sonoma Pharmaceuticals annual revenue?
- What is the all time high annual revenue for Sonoma Pharmaceuticals?
- What is Sonoma Pharmaceuticals annual revenue year-on-year change?
- What is Sonoma Pharmaceuticals quarterly revenue?
- What is the all time high quarterly revenue for Sonoma Pharmaceuticals?
- What is Sonoma Pharmaceuticals quarterly revenue year-on-year change?
- What is Sonoma Pharmaceuticals TTM revenue?
- What is the all time high TTM revenue for Sonoma Pharmaceuticals?
- What is Sonoma Pharmaceuticals TTM revenue year-on-year change?
What is Sonoma Pharmaceuticals annual revenue?
The current annual revenue of SNOA is $12.73 M
What is the all time high annual revenue for Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals all-time high annual revenue is $18.97 M
What is Sonoma Pharmaceuticals annual revenue year-on-year change?
Over the past year, SNOA annual revenue has changed by -$537.00 K (-4.05%)
What is Sonoma Pharmaceuticals quarterly revenue?
The current quarterly revenue of SNOA is $3.56 M
What is the all time high quarterly revenue for Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals all-time high quarterly revenue is $5.77 M
What is Sonoma Pharmaceuticals quarterly revenue year-on-year change?
Over the past year, SNOA quarterly revenue has changed by $0.00 (0.00%)
What is Sonoma Pharmaceuticals TTM revenue?
The current TTM revenue of SNOA is $13.97 M
What is the all time high TTM revenue for Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals all-time high TTM revenue is $20.78 M
What is Sonoma Pharmaceuticals TTM revenue year-on-year change?
Over the past year, SNOA TTM revenue has changed by $0.00 (0.00%)